Cancer‐Associated Fibroblast‐Derived FGF7 Promotes Immune Escape in Oral Squamous Cell Carcinoma via JAK/STAT3‐Mediated PD‐L1 Expression
Molecular Carcinogenesis · 2026
DOI: 10.1002/mc.70152 ↗At a glance
Journal article in Molecular Carcinogenesis, 2026. Written by Qinghua Liu and 4 co-authors. Institution: Department of Stomatology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China. Major MEDLINE topics: STAT3 Transcription Factor, Mouth Neoplasms, B7-H1 Antigen, Carcinoma, Squamous Cell. 38 references. The full text is freely available in PubMed Central. Funded by: Longyan City Science and Technology Plan Project.
Abstract (original language)
Oral squamous cell carcinoma (OSCC) exhibits high recurrence rates, and immune escape within the tumor microenvironment is a critical barrier to effective therapy. This study investigates whether cancer‐associated fibroblast (CAF)‐derived FGF7 promotes immune escape in OSCC through JAK/STAT3 pathway‐mediated PD‐L1. Tumor and adjacent tissues from OSCC patients were analyzed for FGFF7 expression, and the correlations between FGF7 and clinicopathological features were analyzed. CAFs were isolated from OSCC, transfected with plasmids targeting FGF7, and assessed for activation markers, 3D spheroid formation, and epithelial‐mesenchymal transition (EMT) proteins. Co‐culture systems were established to evaluate the malignant behaviors of OSCC cells exposed to modified CAFs through proliferation, migration, invasion, and apoptosis assays. OSCC cells were co‐cultured with CD8 + T cells, followed by measurement of JAK/STAT3 phosphorylation, PD‐L1 expression, T‐cell activation markers, and immune‐related genes. In vivo effects were examined in xenograft models. FGF7 was overexpressed in OSCC tissues and cells, primarily originating from CAFs. FGF7 knockdown in CAFs suppressed activation markers, EMT, and malignant behaviors of OSCC cells. Mechanistically, FGF7 knockdown reduced JAK/STAT3 phosphorylation and PD‐L1 expression, impairing T‐cell cytotoxicity and antigen presentation. A specific STAT3 inhibitor completely reversed FGF7‐induced PD‐L1 upregulation. ChIP‐qPCR confirmed that STAT3 directly binds to the PD‐L1 promoter and activates its transcription. In vivo, CAF‐specific FGF7 knockdown attenuated tumor growth and collagen deposition while increasing CD8 + T‐cell infiltration and apoptosis. Combined FGF7 knockdown and anti‐PD‐L1 therapy synergistically enhanced these effects. CAF‐derived FGF7 drives immune escape and OSCC progression by upregulating PD‐L1 via JAK/STAT3 signaling.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Stomatology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian, China.
ORCID profiles: Qinghua Liu, Dongbin Chen
Funding
- Longyan City Science and Technology Plan Project
Cite
APA
Liu, Q., Chen, D., Lin, J., Wang, Q., & Zhang, F. (2026). Cancer‐Associated Fibroblast‐Derived FGF7 Promotes Immune Escape in Oral Squamous Cell Carcinoma via JAK/STAT3‐Mediated PD‐L1 Expression. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70152
Vancouver
Liu Q, Chen D, Lin J, Wang Q, Zhang F. Cancer‐Associated Fibroblast‐Derived FGF7 Promotes Immune Escape in Oral Squamous Cell Carcinoma via JAK/STAT3‐Mediated PD‐L1 Expression. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70152
BibTeX
@article{Liu2026,
author = {Liu, Qinghua and Chen, Dongbin and Lin, Juncai and Wang, Qisong and Zhang, Fan},
title = {Cancer‐Associated Fibroblast‐Derived FGF7 Promotes Immune Escape in Oral Squamous Cell Carcinoma via JAK/STAT3‐Mediated PD‐L1 Expression},
journal = {Molecular Carcinogenesis},
year = {2026},
doi = {10.1002/mc.70152}
}
EUVIMED